Original Contributions |
From the Department of Applied Chemistry and Microbiology (Nutrition), University of Helsinki, Helsinki, Finland (A.M.T., M.M.); the Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Munich, Germany (J.W., R.L.); and the Department of Nutrition, National Public Health Institute, Helsinki, Finland (A.A.).
AbstractThe effects of stearic
acid (C18:0) and trans-fatty acids
(trans-FAs) on measures of platelet function
and prostacyclin (PGI2) production are poorly
understood in humans. In this controlled dietary study, platelet
function and endothelial PGI2
production were studied in healthy humans after they consumed
diets rich in C18:0 or trans-FAs. For 5 weeks, 80
subjects consumed a baseline diet high in saturated FAs and were then
switched to a diet containing 9.3% of energy as stearic acid or a diet
containing 8.7 energy% as trans-FAs from
hydrogenated vegetable oils for another 5 weeks. All diets contained
32.2 to 33.9 energy% fat, 14.6 to 15.8 energy% saturated plus
trans-FAs, 12.2 to 12.5 energy%
cis-monounsaturated, and 2.9 to
3.5 energy% polyunsaturated FAs. No significant differences between
the C18:0 and trans-FA diets were found in the
urinary excretion of 2,3-dinor-thromboxane B2
or 2,3-dinor-6-keto-prostaglandin F1
. In
vitro production of thromboxane B2 by
platelets as well as urinary excretion of
ß-thromboglobulin were also similar after both
diets. Collagen-induced in vitro aggregation was significantly enhanced
after the C18:0 diet compared with the trans-FA
diet (P=.02), whereas no differences between the diets
were found with ADP. The results indicate similar effects of C18:0 and
trans-FA diets on platelet activation and
endothelial PGI2 production.
Key Words: stearic acid trans-fatty acids platelet activation 2,3-dinor-TXB2 2,3-dinor-6-keto-PGF1
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |